Updates

Author Details

Joe Pierce

April 8, 2021April 8, 2021
Effects of War, Dementia Animated in Short Film ‘Winter Memories’

Zahra Kababian had a special bond with her father, and even though he died suddenly 10 years ago, it’s the memories they shared that keeps ... Read more
April 5, 2021April 1, 2021
Agent Orange Exposure Increases Risk of Dementia in Vietnam Veterans

The Vietnam War Veterans Recognition Act, signed into law in 2017, designates March 29 of each year as National Vietnam War Veterans Day. In 1973, ... Read more
April 5, 2021April 5, 2021
FDA Rejects Nuplazid to Treat Dementia-related Psychosis

The U.S. Food and Drug Administration (FDA) has rejected Acadia Pharmaceuticals’ request that Nuplazid (pimavanserin) be the first approved treatment of hallucinations and delusions associated with dementia-related psychosis. ... Read more
April 1, 2021April 1, 2021
Montana Residents May Order Free Children’s Storybook About Alzheimer’s

Montana residents who wish to help their children or young relatives better understand Alzheimer’s disease can now access a free storybook and reading guide. The ... Read more
March 29, 2021March 25, 2021
Alzheimer’s Organization Delivers Grim Statistics in Annual Report

The Alzheimer’s Association recently released its 2021 Facts and Figures report. Compared to the 2020 report, there are a few grim changes regarding the most ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Author Details

Joe Pierce

Thanks! Please check your email for a confirmation email.

November 8, 2017November 8, 2017

Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment

News

Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data presented ... Read more

Effects of War, Dementia Animated in Short Film ‘Winter Memories’

Agent Orange Exposure Increases Risk of Dementia in Vietnam Veterans

FDA Rejects Nuplazid to Treat Dementia-related Psychosis

Montana Residents May Order Free Children’s Storybook About Alzheimer’s

Alzheimer’s Organization Delivers Grim Statistics in Annual Report

Sargramostim, Immune System Activator, May Aid Cognition, Small Trial Finds

Donanemab Shows Potential for Early Alzheimer’s in Phase 2 Trial

Sulbutamol, for Respiratory Ills, Seen to Improve Blood Flow in Brain

Neurostimulation Slows Decline in Mild-to-moderate Alzheimer’s, Trial Finds

Flu and Pneumonia Vaccines Lessen Risk of Alzheimer’s Disease

Noninvasive Genetic Risk Test for Alzheimer’s Coming to EU, US

Subscribe to our mailing list

FDA Finds ‘Deficiencies’ in Request for Nuplazid to Treat Dementia-Related Psychosis

Caregivers Must Protect Seniors from Scammers, Especially During Tax Season

Racial Discrimination Can Be Barrier in Healthcare, Surveys Find

Pivotal Phase 3 Trials of Oral Simufilam Planned for Year’s End

Phase 1 Trial to Test BDNF Gene Therapy in Alzheimer’s Patients

Grants of $4.6M to Support Trials of Cancer Therapy in Early Alzheimer’s

Dementia Patients Have a Greater Risk of Contracting COVID-19

UsAgainstAlzheimer’s Calls for $289M Hike in Federal Funds for Research

HFC to Host CareCon, Virtual Event for Caregivers

Remaining in the Moment Is the Best Strategy for Alzheimer’s Caregivers

Oral Simufilam Found to Improve Cognition, Behavior After 6 Months’ Use

Alzheimer’s Association Webinar Tackles Care Disparities for Blacks in US

Seniors Lack Easy Access to Important Health Information

Adira Foundation Arises From Life-altering Accident to Help Those With Chronic Ills

Phase 3 Trial of Therapy for Inflammation, Insulin-sensitivity in Alzheimer’s to Open

Troriluzole Fails to Ease Cognitive Impairments in Phase 2/3 Trial

New Legislation Is a Positive Step Toward Preventing Elder Abuse

FDA Extends Its Aducanumab Review With Decision Expected in June

Patients, Caregivers Urged to Get COVID-19 Vaccines ASAP

COVID-19 Vaccine Should Be a Priority for Alzheimer’s Patients and Caregivers

Non-invasive Neurostimulation Device Wins FDA’s Breakthrough Status

New Technique May Enable Early Diagnosis of Alzheimer’s

Anticipating 2021 When Caregiving Feels Like ‘Groundhog Day’

Axsome Launches AXS-05 Phase 3 Trial for Alzheimer’s-associated Agitation

Donanemab Found to Slow Cognitive, Functional Decline in Early Alzheimer’s

BXCL501 Led to Fast, Safe, Durable Drop in Agitation in Dementia Patients

Support for Research, Patient Care in US 2021 Budget Wins Praise

Phase 3 Trial of Diabetes Treatment in Early Alzheimer’s Patients Planned

Directory Connects Alzheimer’s Caregivers With Valuable Resources

Fujirebio Seeks FDA’s Premarket Approval for Diagnostic Test

Biogen, Eisai Request Approval of Aducanumab for Alzheimer’s in Japan